<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of inserm-02332894</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-21T17:46:10+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma</title>
            <author role="crp">
              <persName>
                <forename type="first">Zuzana Macek</forename>
                <surname>Jilkova</surname>
              </persName>
              <email type="md5">08a0f676dea5c507b526d3af5d9c4c59</email>
              <email type="domain">gmail.com</email>
              <idno type="idhal" notation="string">zuzana-macek-jilkova</idno>
              <idno type="idhal" notation="numeric">1056924</idno>
              <idno type="halauthorid" notation="string">1687708-1056924</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-2553-5971</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=jwPA78gAAAAJ</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/N-4051-2014</idno>
              <affiliation ref="#struct-472784"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Ayca</forename>
                <forename type="middle">Zeybek</forename>
                <surname>Kuyucu</surname>
              </persName>
              <idno type="halauthorid">1686991-0</idno>
              <affiliation ref="#struct-472784"/>
              <affiliation ref="#struct-571938"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Keerthi</forename>
                <surname>Kurma</surname>
              </persName>
              <idno type="halauthorid">1686900-0</idno>
              <affiliation ref="#struct-472784"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Ahmad</forename>
                <surname>Pour</surname>
              </persName>
              <idno type="halauthorid">1686992-0</idno>
              <affiliation ref="#struct-472784"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Gaël</forename>
                <forename type="middle">S</forename>
                <surname>Roth</surname>
              </persName>
              <idno type="halauthorid">1686993-0</idno>
              <affiliation ref="#struct-472784"/>
              <affiliation ref="#struct-34738"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Giovanni</forename>
                <surname>Abbadessa</surname>
              </persName>
              <idno type="halauthorid">1686994-0</idno>
              <affiliation ref="#struct-571936"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Yi</forename>
                <surname>Yu</surname>
              </persName>
              <email type="md5">646d066b4db043392e0b8a4e08cdf2cb</email>
              <email type="domain">telecom-bretagne.fr</email>
              <idno type="idhal" notation="numeric">1134186</idno>
              <idno type="halauthorid" notation="string">444920-1134186</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-7206-3487</idno>
              <idno type="IDREF">https://www.idref.fr/25478772X</idno>
              <affiliation ref="#struct-571936"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Brian</forename>
                <surname>Schwartz</surname>
              </persName>
              <idno type="halauthorid">1686995-0</idno>
              <affiliation ref="#struct-571936"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Nathalie</forename>
                <surname>Sturm</surname>
              </persName>
              <idno type="halauthorid">199107-0</idno>
              <affiliation ref="#struct-472784"/>
              <affiliation ref="#struct-571937"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Patrice</forename>
                <forename type="middle">N.</forename>
                <surname>Marche</surname>
              </persName>
              <email type="md5">6c106936fba4098da455b2aa947eb93d</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="string">patrice-marche</idno>
              <idno type="idhal" notation="numeric">170615</idno>
              <idno type="halauthorid" notation="string">135130-170615</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/K-5060-2013</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-8930-9340</idno>
              <idno type="IDREF">https://www.idref.fr/067388965</idno>
              <affiliation ref="#struct-472784"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Pierre</forename>
                <surname>Hainaut</surname>
              </persName>
              <email type="md5">e3b77dc1d25f97857214d8eb2fecd080</email>
              <email type="domain">univ-grenoble-alpes.fr</email>
              <idno type="idhal" notation="string">pierre-hainaut</idno>
              <idno type="idhal" notation="numeric">1058094</idno>
              <idno type="halauthorid" notation="string">229059-1058094</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=hPgJw8EAAAAJ</idno>
              <affiliation ref="#struct-472784"/>
            </author>
            <author role="crp">
              <persName>
                <forename type="first">Thomas</forename>
                <surname>Decaens</surname>
              </persName>
              <email type="md5">baf66438a0131156d32efea75ab6d336</email>
              <email type="domain">chu-grenoble.fr</email>
              <idno type="idhal" notation="numeric">757228</idno>
              <idno type="halauthorid" notation="string">174384-757228</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-0928-0048</idno>
              <idno type="IDREF">https://www.idref.fr/077283465</idno>
              <affiliation ref="#struct-472784"/>
              <affiliation ref="#struct-571938"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Patrice</forename>
                <surname>MARCHE</surname>
              </persName>
              <email type="md5">6c106936fba4098da455b2aa947eb93d</email>
              <email type="domain">inserm.fr</email>
            </editor>
            <funder>Work was funded by la Ligue contre le Cancer CD63 (2016-R16145CC), AZK was supported by The Scientific and Technological Research Council of Turkey (TUBITAK 2214B).</funder>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2019-10-25 10:14:41</date>
              <date type="whenModified">2026-04-02 15:54:04</date>
              <date type="whenReleased">2019-10-25 11:32:28</date>
              <date type="whenProduced">2018-02-16</date>
              <date type="whenEndEmbargoed">2019-10-25</date>
              <ref type="file" target="https://inserm.hal.science/inserm-02332894v1/document">
                <date notBefore="2019-10-25"/>
              </ref>
              <ref type="file" subtype="greenPublisher" n="1" target="https://inserm.hal.science/inserm-02332894v1/file/Macek%20Jilkova_Oncotarget-2018.pdf" id="file-2332894-2243912">
                <date notBefore="2019-10-25"/>
              </ref>
              <ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834253"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="540278">
                <persName>
                  <forename>Patrice</forename>
                  <surname>MARCHE</surname>
                </persName>
                <email type="md5">6c106936fba4098da455b2aa947eb93d</email>
                <email type="domain">inserm.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">inserm-02332894</idno>
            <idno type="halUri">https://inserm.hal.science/inserm-02332894</idno>
            <idno type="halBibtex">jilkova:inserm-02332894</idno>
            <idno type="halRefHtml">&lt;i&gt;Oncotarget&lt;/i&gt;, 2018, 9 (13), pp.11145-11158. &lt;a target="_blank" href="https://dx.doi.org/10.18632/oncotarget.24298"&gt;&amp;#x27E8;10.18632/oncotarget.24298&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Oncotarget, 2018, 9 (13), pp.11145-11158. &amp;#x27E8;10.18632/oncotarget.24298&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-2332894-2243912"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
            <idno type="stamp" n="UGA">HAL Grenoble Alpes</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="UGA-COMUE">Université Grenoble Alpes [2016-2019]</idno>
            <idno type="stamp" n="IAB_GRENOBLE">IAB - Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble)</idno>
            <idno type="stamp" n="TEST-UGA">TEST-UGA</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma</title>
                <author role="crp">
                  <persName>
                    <forename type="first">Zuzana Macek</forename>
                    <surname>Jilkova</surname>
                  </persName>
                  <email type="md5">08a0f676dea5c507b526d3af5d9c4c59</email>
                  <email type="domain">gmail.com</email>
                  <idno type="idhal" notation="string">zuzana-macek-jilkova</idno>
                  <idno type="idhal" notation="numeric">1056924</idno>
                  <idno type="halauthorid" notation="string">1687708-1056924</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-2553-5971</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=jwPA78gAAAAJ</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/N-4051-2014</idno>
                  <affiliation ref="#struct-472784"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Ayca</forename>
                    <forename type="middle">Zeybek</forename>
                    <surname>Kuyucu</surname>
                  </persName>
                  <idno type="halauthorid">1686991-0</idno>
                  <affiliation ref="#struct-472784"/>
                  <affiliation ref="#struct-571938"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Keerthi</forename>
                    <surname>Kurma</surname>
                  </persName>
                  <idno type="halauthorid">1686900-0</idno>
                  <affiliation ref="#struct-472784"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Ahmad</forename>
                    <surname>Pour</surname>
                  </persName>
                  <idno type="halauthorid">1686992-0</idno>
                  <affiliation ref="#struct-472784"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Gaël</forename>
                    <forename type="middle">S</forename>
                    <surname>Roth</surname>
                  </persName>
                  <idno type="halauthorid">1686993-0</idno>
                  <affiliation ref="#struct-472784"/>
                  <affiliation ref="#struct-34738"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Giovanni</forename>
                    <surname>Abbadessa</surname>
                  </persName>
                  <idno type="halauthorid">1686994-0</idno>
                  <affiliation ref="#struct-571936"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Yi</forename>
                    <surname>Yu</surname>
                  </persName>
                  <email type="md5">646d066b4db043392e0b8a4e08cdf2cb</email>
                  <email type="domain">telecom-bretagne.fr</email>
                  <idno type="idhal" notation="numeric">1134186</idno>
                  <idno type="halauthorid" notation="string">444920-1134186</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-7206-3487</idno>
                  <idno type="IDREF">https://www.idref.fr/25478772X</idno>
                  <affiliation ref="#struct-571936"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Brian</forename>
                    <surname>Schwartz</surname>
                  </persName>
                  <idno type="halauthorid">1686995-0</idno>
                  <affiliation ref="#struct-571936"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Nathalie</forename>
                    <surname>Sturm</surname>
                  </persName>
                  <idno type="halauthorid">199107-0</idno>
                  <affiliation ref="#struct-472784"/>
                  <affiliation ref="#struct-571937"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Patrice</forename>
                    <forename type="middle">N.</forename>
                    <surname>Marche</surname>
                  </persName>
                  <email type="md5">6c106936fba4098da455b2aa947eb93d</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="string">patrice-marche</idno>
                  <idno type="idhal" notation="numeric">170615</idno>
                  <idno type="halauthorid" notation="string">135130-170615</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/K-5060-2013</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-8930-9340</idno>
                  <idno type="IDREF">https://www.idref.fr/067388965</idno>
                  <affiliation ref="#struct-472784"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Pierre</forename>
                    <surname>Hainaut</surname>
                  </persName>
                  <email type="md5">e3b77dc1d25f97857214d8eb2fecd080</email>
                  <email type="domain">univ-grenoble-alpes.fr</email>
                  <idno type="idhal" notation="string">pierre-hainaut</idno>
                  <idno type="idhal" notation="numeric">1058094</idno>
                  <idno type="halauthorid" notation="string">229059-1058094</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=hPgJw8EAAAAJ</idno>
                  <affiliation ref="#struct-472784"/>
                </author>
                <author role="crp">
                  <persName>
                    <forename type="first">Thomas</forename>
                    <surname>Decaens</surname>
                  </persName>
                  <email type="md5">baf66438a0131156d32efea75ab6d336</email>
                  <email type="domain">chu-grenoble.fr</email>
                  <idno type="idhal" notation="numeric">757228</idno>
                  <idno type="halauthorid" notation="string">174384-757228</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-0928-0048</idno>
                  <idno type="IDREF">https://www.idref.fr/077283465</idno>
                  <affiliation ref="#struct-472784"/>
                  <affiliation ref="#struct-571938"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">102112</idno>
                <idno type="issn">1949-2553</idno>
                <title level="j">Oncotarget</title>
                <imprint>
                  <publisher>Impact journals</publisher>
                  <biblScope unit="volume">9</biblScope>
                  <biblScope unit="issue">13</biblScope>
                  <biblScope unit="pp">11145-11158</biblScope>
                  <date type="datePub">2018-02-16</date>
                </imprint>
              </monogr>
              <idno type="doi">10.18632/oncotarget.24298</idno>
              <idno type="pubmed">29541403</idno>
              <idno type="pubmedcentral">PMC5834253</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">AKT inhibitor</term>
                <term xml:lang="en">DEN-induced model</term>
                <term xml:lang="en">fibrosis</term>
                <term xml:lang="en">combination treatment</term>
                <term xml:lang="en">liver cancer</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.mhep.heg">Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology</classCode>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Copyright: Macek Jilkova et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT The prognosis of patients with advanced hepatocellular carcinoma (HCC) is very poor. The AKT pathway is activated in almost half of HCC cases and in addition, long term exposure to conventional drug treatment of HCC, sorafenib, often results in over-activation of AKT, leading to HCC resistance. Therefore, it is important to assess the safety and the efficacy of selective allosteric AKT inhibitor ARQ 092 (Miransertib) in combination with sorafenib. Here, we demonstrated in vitro that the combination of ARQ 092 with sorafenib synergistically suppressed proliferation, promoted apoptosis, and reduced migration. To test the effect of the combination in vivo, rats with diethylnitrosamine-induced cirrhosis and fully developed HCC were randomized and treated with vehicle, sorafenib, ARQ 092 or the combination of ARQ 092 with sorafenib; (n=7/group) for 6 weeks. Tumor progression, size of tumors and the mean tumor number were significantly reduced by the combination treatment compared to the control or single treatments. This effect was associated with a significant increase in apoptotic response and reduction in proliferation and angiogenesis. Sirius red staining showed a decrease in liver fibrosis. Moreover, treatments improved immune response in blood and in tumor microenvironment. Thus, the combination of ARQ 092 with sorafenib potentiates inhibition of tumor progression and gives the possibility of therapeutic improvement for patients with advanced HCC.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-472784" status="OLD">
          <idno type="IdRef">200912658</idno>
          <idno type="RNSR">201622378J</idno>
          <orgName>Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble)</orgName>
          <orgName type="acronym">IAB</orgName>
          <date type="start">2016-01-01</date>
          <date type="end">2019-12-31</date>
          <desc>
            <address>
              <addrLine>Institut pour l'Avancée des BiosciencesCentre de Recherche UGA / Inserm U 1209 / CNRS UMR 5309Site Santé - Allée des Alpes 38700 La Tronche</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://iab.univ-grenoble-alpes.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-200221" type="direct"/>
            <relation active="#struct-199980" type="indirect"/>
            <relation active="#struct-257328" type="direct"/>
            <relation name="U1209" active="#struct-303623" type="direct"/>
            <relation name="UMR5309" active="#struct-441569" type="direct"/>
            <relation active="#struct-445543" type="direct"/>
          </listRelation>
        </org>
        <org type="regrouplaboratory" xml:id="struct-571938" status="INCOMING">
          <orgName>Department of Bioengineering [Izmir, Turkey]</orgName>
          <desc>
            <address>
              <country key="TR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-322511" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-34738" status="VALID">
          <orgName>Département de Gastroentérologie et hépatologie</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-51016" type="direct"/>
            <relation active="#struct-257328" type="direct"/>
            <relation active="#struct-300199" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-571936" status="INCOMING">
          <orgName>ArQule Inc. [Woburn, MA, USA]</orgName>
          <desc>
            <address>
              <country key="US"/>
            </address>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-571937" status="INCOMING">
          <orgName>Anatomie et de Cytologie Pathologiques [CHU Grenoble]</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-257328" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-200221" status="VALID">
          <orgName>Établissement Français du Sang Auvergne-Rhône-Alpes [Lyon]</orgName>
          <orgName type="acronym">EFS Auvergne-Rhône-Alpes - Lyon</orgName>
          <desc>
            <address>
              <addrLine>Site de Lyon. 3 Rue du Vercors 69364 Lyon</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.efs.sante.fr/lefs-en-auvergne-rhone-alpes</ref>
          </desc>
          <listRelation>
            <relation active="#struct-199980" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-199980" status="VALID">
          <orgName>Établissement Français du Sang [La Plaine Saint-Denis]</orgName>
          <orgName type="acronym">EFS</orgName>
          <date type="start">2000-01-01</date>
          <desc>
            <address>
              <addrLine>20 Avenue du Stade de France 93218 La Plaine Saint Denis</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.dondusang.net</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-257328" status="VALID">
          <idno type="IdRef">034137076</idno>
          <idno type="ROR">https://ror.org/041rhpw39</idno>
          <orgName>CHU de Grenoble-Alpes - Centre Hospitalier Universitaire CHU Grenoble</orgName>
          <orgName type="acronym">CHUGA</orgName>
          <desc>
            <address>
              <addrLine>CS 1021738043 Grenoble cedex 9</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-grenoble.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-445543" status="OLD">
          <idno type="IdRef">188399275</idno>
          <idno type="ROR">https://ror.org/02rx3b187</idno>
          <orgName>Université Grenoble Alpes [2016-2019]</orgName>
          <orgName type="acronym">UGA [2016-2019]</orgName>
          <date type="start">2016-01-01</date>
          <date type="end">2019-12-31</date>
          <desc>
            <address>
              <addrLine>38058 Grenoble cedex</addrLine>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-322511" status="VALID">
          <idno type="ROR">https://ror.org/03stptj97</idno>
          <orgName>Izmir Institute of Technology</orgName>
          <orgName type="acronym">IZTECH</orgName>
          <desc>
            <address>
              <addrLine>Urla, İzmir 35430 Türkiye</addrLine>
              <country key="TR"/>
            </address>
            <ref type="url">http://www.iyte.edu.tr</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-51016" status="OLD">
          <idno type="IdRef">026404796</idno>
          <idno type="ROR">https://ror.org/02aj0kh94</idno>
          <orgName>Université Joseph Fourier - Grenoble 1</orgName>
          <orgName type="acronym">UJF</orgName>
          <date type="end">2015-12-31</date>
          <desc>
            <address>
              <addrLine>BP 53 - 38041 Grenoble Cedex 9</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.ujf-grenoble.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300199" status="VALID">
          <orgName>Hôpital Michallon</orgName>
          <desc>
            <address>
              <addrLine>CHU Grenoble-Alpes</addrLine>
              <country key="FR"/>
            </address>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>